Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke

Toxicology Letters

Volumn 149, Issue 1-3, 2004, Pages 269-280

  Georgiadis, P ^a   Demopoulos, N A ^b   Topinka, J ^c   Stephanou, G ^b   Stoikidou, M ^d   Bekyrou, M ^a   Katsouyianni, K ^d   Sram, R ^c   Autrup, H ^e   Kyrtopoulos, S A ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

Aberrant cells; Air pollution; CYP1A1; CYP1B1; DNA adducts; ETS; GSTM1; GSTP1; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; EPOXIDE; GLUTATHIONE TRANSFERASE; HYDROLASE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

AIR POLLUTION; CHROMOSOME ABERRATION; CONFERENCE PAPER; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; ENZYME POLYMORPHISM; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; GREECE; ISOTOPE LABELING; LYMPHOCYTE COUNT; MUTANT; NULL ALLELE; PRIORITY JOURNAL; RURAL AREA; URBAN AREA;

ACETYLTRANSFERASES; AIR POLLUTION; ARYL HYDROCARBON HYDROXYLASES; CHROMOSOME ABERRATIONS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DNA; DNA ADDUCTS; EPOXIDE HYDROLASES; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOCYTES; MUTAGENS; MUTATION; PENETRANCE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 11144358182     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.038     Document Type: Conference Paper

References (41)

1. Aklillu E., Oscarson M., Hidestrand M., Leidvik B., Otter C., Ingelman-Sundberg M. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population. Mol. Pharmacol. 61(3):2002;586-594.
2. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464:2000;65-76.
3. Autrup J.L., Thomassen L.H., Olsen J.H., Wolf H., Autrup H. Glutathione S-transferases as risk factors in prostate cancer. Eur. J. Cancer Prev. 8(6):1999;525-532.
4. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev. 9:2000;3-28.
5. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., Doehmer J., Ward J.M., Jefcoate C.R., Gonzalez F.J. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1977-1982.
6. Butkiewicz D., Grzybowska E., Hemminki K., Ovrebo S., Haugen A., Motykiewicz G., Chorazy M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
7. Firozi P.F., Bondy M.L., Sahin A.A., Chang P., Lukmanji F., Singletary E.S., Hassan M.M., Li D. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis. 23:2002;301-306.
8. Georgiadis P., Stoikidou M., Topinka J., Kaila S., Gioka M., Katsouyanni K., Sram R., Kyrtopoulos S.A. Personal exposures to PM(2.5) and polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke at two locations in Greece. J. Expos. Anal. Environ. Epidemiol. 11:2001;169-183.
9. Georgiadis P., Topinka J., Stoikidou M., Kaila S., Gioka M., Katsouyanni K., Sram R., Autrup H., Kyrtopoulos S.A. Biomarkers of genotoxicity of air pollution (the AULIS project): bulky DNA adducts in subjects with moderate to low exposures to airborne polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke and other parameters. Carcinogenesis. 22:2001;1447-1457.
10. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
11. Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3:1994;421-428.
12. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., Wolf C.R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5275-5280.
13. Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat. Res. 482:2001;11-19.
14. Ishibe N., Hankinson S.E., Colditz G.A., Spiegelman D., Willett W.C., Speizer F.E., Kelsey K.T., Hunter D.J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res. 58(4):1998;667-671.
15. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 263:1990;131-133.
16. Kiyohara C., Hirohata T., Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn. J. Cancer Res. 87:1996;18-24.
17. Kyrtopoulos S.A., Georgiadis P., Autrup H., Demopoulos N.A., Farmer P., Haugen A., Katsouyanni K., Lambert B., Ovrebo S., Sram R., Topinka J., Stefanou G., Demopoulos N. Biomarkers of genotoxicity of urban air pollution. Overview and descriptive data from a molecular epidemiology study on populations exposed to moderate-to-low levels of polycyclic aromatic hydrocarbons: the AULIS project. Mutat. Res. 20(496):2001;207-228.
18. Marcus P.M., Vineis P., Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics. 10:2000;115-122.
19. Moysich K.B., Shields P.G., Freudenheim J.L., Schisterman E.F., Vena J.E., Kostyniak P., Greizerstein H., Marshall J.R., Graham S., Ambrosone C.B. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8(1):1999;41-44.
20. Pastorelli R., Guanci M., Cerri A., Negri E., La Vecchia C., Fumagalli F., Mezzetti M., Cappelli R., Panigalli T., Fanelli R., Airoldi L. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol. Biomarkers Prev. 7:1998;703-709.
21. Pavanello S., Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat. Res. 463:2000;285-308.
22. Perera F.P., Mooney L.A., Stampfer M., Phillips D.H., Bell D.A., Rundle A., Cho S., Tsai W.Y., Ma J., Blackwood A., Tang D. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis. 23(10):2002;1641-1646.
23. Rojas M., Cascorbi I., Alexandrov K., Kriek E., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis. 21:2000;35-41.
24. Safe S.H. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67:1995;247-281.
25. Song N., Tan W., Xing D., Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis. 22:2001;11-16.
26. Sram R.J., Binkova B. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999. Environ. Health Perspect. 108(Suppl. 1):2000;57-70.
27. Stucker I., Hirvonen A., De Waziers I., Cabelguenne A., Mitrunen K., Cenee S., Koum-Besson E., Hemon D., Beaune P., Loriot M.A. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 23:2002;1475-1481.
28. Sundberg K., Widersten M., Seidel A., Mannervik B., Jernstrom B. Glutathione conjugation of bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferases M1-1 and P1-1. Chem. Res. Toxicol. 10:1997;1221-1227.
29. Tang D.L., Rundle A., Warburton D., Santella R.M., Tsai W.Y., Chiamprasert S., Hsu Y.Z., Perera F.P. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis. 19:1998;1949-1953.
30. Teixeira J.P., Gaspar J., Martinho G., Silva S., Rodrigues S., Mayan O., Martin E., Farmer P.B., Rueff J. Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in genes GSTP1, GSTM1, GSTT1 and CYP1A1. Mutat. Res. 517:2002;147-155.
31. Topinka J., Binkova B., Mrackova G., Stavkova Z., Peterka V., Benes I., Dejmek J., Lenicek J., Pilcik T., Sram R.J. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population. Environ. Mol. Mutagen. 30:1997;184-195.
32. Vaury C., Laine R., Noguiez P., de Coppet P., Jaulin C., Praz F., Pompon D., Amor-Gueret M. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res. 55:1995;5520-5523.
33. Viezzer C., Norppa H., Clonfero E., Gabbani G., Mastrangelo G., Hirvonen A., Celotti L. Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat. Res. 431:1999;259-269.
34. Vineis P., Martone T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology. 6:1995;455-457.
35. Vlastos D., Stephanou G., Demopoulos N.A. Effects of cetirizine dihydrochloride on human lymphocytes in vitro: evaluation of chromosome aberrations and sister Chromatid exchanges. Skin Pharmacol. Appl. Skin Physiol. 11:1998;104-110.
36. Wang Y., Ichiba M., Iyadomi M., Zhang J., Tomokuni K. Effects of genetic polymorphism of metabolic enzymes, nutrition, and lifestyle factors on DNA adduct formation in lymphocytes. Ind. Health. 36:1998;337-346.
37. Whyatt R.M., Perera F.P., Jedrychowski W., Santella R.M., Garte S., Bell D.A. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol. Biomarkers Prev. 9:2000;207-212.
38. Willett W.C. Diet, nutrition, and avoidable cancer. Environ. Health Perspect. 103(Suppl. 8):1995;165-170.
39. Williams J.A., Phillips D.H. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res. 60:2000;4667-4677.
40. Zheng W., Xie D.W., Jin F., Cheng J.R., Dai Q., Wen W.Q., Shu X.O., Gao Y.T. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 9(2):2000;147-150.
41. Zhou W., Thurston S.W., Liu G., Xu L.L., Miller D.P., Wain J.C., Lynch T.J., Su L., Christiani D.C. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol. Biomarkers Prev. 10:2001;461-466.